K. J. Lafferty - Concepedia

Author

K. J. Lafferty

Also Known As

K J LAFFERTY, K J Lafferty, K Lafferty, K. J. LAFFERTY, K. J. Lafferty, K. LAFFERTY, K. Lafferty, K.J Lafferty, K.J. Lafferty, Kate Lafferty

Publications

2.7K

Citations

H-Index

111

Concepts

All Affiliations

Australian National University University of Colorado Health King's College Hospital King's College School Dulwich Community Hospital

About

K. J. Lafferty is an author at Australian National University specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	31	1.7K
2	Health Sciences	5	5	182
3	Allergy	3	3	90
4	Education	1	1	65
5	Natural Sciences	1	1	26

K. J. Lafferty

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Kathryn Haskins, Mary Portas, Barbara Bergman, Proceedings of the National Academy of Sciences T-regulatory CellImmunologyPathologyPancreas TransplantationImmunotherapy	1989	242
The role of CD4+ and CD8+ T cells in the destruction of islet grafts by spontaneously diabetic mice. Y Wang, Oscar Pontesilli, Ronald G. Gill, Proceedings of the National Academy of Sciences Cd4+ CellsLymphocyte DevelopmentT-regulatory CellDiabetic MiceImmunology	1991	149
Inhibition of T‐Cell Activity by Cyclosporin A Linda Andrus, K. J. Lafferty Scandinavian Journal of Immunology	1982	129
Combined Treatment With Nicotinamide and Desferrioxamine Prevents Islet Allograft Destruction in NOD Mice I. Nomikos, Stephen J. Prowse, Patrizia Carotenuto, Diabetes Oxygen-derived Free RadicalsImmunologyPancreas TransplantationImmunotherapyOxidative Stress	1986	109
Natural progesterone and antihypertensive action. P B Rylance, M Brincat, K. J. Lafferty, BMJ HypertensionHormonal ContraceptiveBlood PressureCardiovascular DiseaseMedicine	1985	103
The enhancement of virus infectivity by antibody R.A Hawkes, K. J. Lafferty Virology VaccinationImmunologyAntiviral ResponseVirologyAntibody Engineering	1967	99
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial PK Judge, Natalie Staplin, KJ Mayne, The Lancet Diabetes & Endocrinology	2023	88
The interaction between virus and antibody K. J. Lafferty Virology VaccinationViral PathogenesisImmunologyVirologyVirus-host Interaction	1963	84
The interaction between virus and antibody K. J. Lafferty, S. J. Oertelis Virology VaccinationViral PathogenesisImmunologyVirologyVirus-host Interaction	1963	83
The interaction between virus and antibody K. J. Lafferty Virology VaccinationViral PathogenesisImmunologyVirologyVirus-host Interaction	1963	83

Page 1